Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9402681 | Journal of Surgical Research | 2005 | 12 Pages |
Abstract
Arterial collateralization and SBP increased significantly following VEGF vector administration, which was reversed by the Ang-2 vector. Development of antibody against VSV G can limit repeated injections of vector. Future experiments will involve the addition of other pro-angiogenic factors, repeated vector administration, and alternative routes of vector delivery.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Lori D. M.D., Robin E. B.A., Daryl Schulz, Grzegorz L. M.D., Ph.D., Scott A. M.D., Joseph S. M.D., Albert E. M.D., Richard E. M.D., Ph.D.,